The Role of Growth Hormone and Insulin Growth Factor 1 in the Development of Non-Alcoholic Steato-Hepatitis: A Systematic Review
Cells · 2023
DOI: 10.3390/cells12040517 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cells, 2023. Verfasst von Luca Cristin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Surgery, University of Verona, 37134 Verona, Italy. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Human Growth Hormone, Hepatitis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic and obese patients have a high prevalence of non-alcoholic fatty liver disease (NAFLD). This condition groups a spectrum of conditions varying from simple steatosis to non-alcoholic steatohepatitis (NASH), with or without fibrosis. Multiple factors are involved in the development of NAFLD. However, details about its pathogenesis and factors that promote the progression to NASH are still missing. Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) regulate metabolic, immune, and hepatic stellate cell functions. Increasing evidence suggests they may have roles in the progression from NAFLD to NASH. Following the PRISMA reporting guidelines, we conducted a systematic review to evaluate all clinical and experimental studies published in the literature correlating GH and IGF-1 to inflammation and fibrosis in NAFLD and NASH. Our results showed that GH and IGF-1 have a fundamental role in the pathogenesis of NASH, acting in slightly different ways to produce a synergic effect. Indeed, GH may mediate its protective effect in the pathogenesis of NASH by regulating lipogenesis pathways, while IGF-1 has the same effect by regulating cholesterol transport. Therefore, they could be used as therapeutic strategies in preventing NAFLD progression to NASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Surgery, University of Verona, 37134 Verona, Italy.
- Department of Immunology, University of Verona, 37134 Verona, Italy.
- Department of Surgery, University of Illinois Chicago, Chicago, IL 60607, USA.
- Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
- General Surgery and Liver Transplantation Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
ORCID-Profile: Alessandro Martinino, Juan Pablo Scarano Pereira, Francesco Giovinazzo
Zitieren
APA
Cristin, L., Montini, A., Martinino, A., Scarano Pereira, J. P., Giovinazzo, F., & Agnes, S. (2023). The Role of Growth Hormone and Insulin Growth Factor 1 in the Development of Non-Alcoholic Steato-Hepatitis: A Systematic Review. Cells. https://doi.org/10.3390/cells12040517
Vancouver
Cristin L, Montini A, Martinino A, Scarano Pereira JP, Giovinazzo F, Agnes S. The Role of Growth Hormone and Insulin Growth Factor 1 in the Development of Non-Alcoholic Steato-Hepatitis: A Systematic Review. Cells. 2023. doi:10.3390/cells12040517
BibTeX
@article{Cristin2023,
author = {Cristin, Luca and Montini, Amalia and Martinino, Alessandro and Scarano Pereira, Juan Pablo and Giovinazzo, Francesco and Agnes, Salvatore},
title = {The Role of Growth Hormone and Insulin Growth Factor 1 in the Development of Non-Alcoholic Steato-Hepatitis: A Systematic Review},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12040517}
}
EUVIMED